140410 — Mezzion Pharma Share News
0.000.00%
Last trade - 00:00- KR₩2tn
- KR₩2tn
- KR₩8bn
Brief: Mezzion Reports Pre-Ind FDA Feedback On The Development Of Udenafil In Adpkd
Brief: Mezzion Pharmaceuticals Appoints Ridwan Shabsigh As President & Chief Operating Officer
Brief: Mezzion Pharmaceuticals Reaches Key Enrollment Milestone In World's Largest Fontan Clinical Trial
Brief: Mezzion Pharmaceuticals Announces Dr Rahul Rathod As Global Principal Investigator For The Confirmatory Pivotal Phase 3 Trial FUEL-2
Brief: Mezzion Pharma Submits Protocol For Confirmatory Pivotal Phase 3 Trial
Brief: Mezzion Pharma Announces Positive Data Presented To FDA In Type C Meeting
Brief: Mezzion Announces Submission Of NDA For Its Orphan Drug Udenafil
Brief: Mezzion Pharma Says Conducted Type C Meeting With FDA
Brief: Mezzion Pharma Says Cancels 4.4 Bln Won Worth Of Its Treasury Shares
Brief: Mezzion Pharma to sell 150,000 shares at 55,900 won/share
Brief: Mezzion Pharma to dispose treasury shares for 8.33 bln won
Brief: Mezzion Pharma to dispose treasury shares for 4.65 bln won
Brief: Mezzion Pharma lowers exercise price of second series bonds with warrants to 25,500 won/share